dc.contributor.author | Nilsen, Øivind Anti | |
dc.contributor.author | Raknerud, Arvid | |
dc.contributor.author | Iancu, Diana-Cristina | |
dc.date.accessioned | 2021-03-16T12:06:40Z | |
dc.date.available | 2021-03-16T12:06:40Z | |
dc.date.created | 2020-09-16T13:34:26Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | Research Policy, 49 (7), 104067 | en_US |
dc.identifier.issn | 0048-7333 | |
dc.identifier.uri | https://hdl.handle.net/11250/2733629 | |
dc.description.abstract | We analyse all the major sources of direct and indirect research and development (R&D) support to the business enterprise sector in a single country, Norway, for the period 2002–2013, treating the financial support for R&D from several instruments as a multivariate dose exposure. The output additionality of support to incumbent firms that regularly perform R&D (R&D-incumbents), which obtain about 65 per cent of all R&D support to business enterprises, is insignificant for any instrument or policy mixture. However, the estimated additionality of support to R&D-starters (firms without prior R&D activity), which obtain about 30 per cent of all R&D support, is generally positive. In this firm category, the main instruments for direct R&D support in Norway generate significantly less output and economic activity per NOK 1 million in support than do tax credits, despite the fact these instruments manage large project portfolios at considerable administrative costs. We do not identify positive effects of R&D support on labour productivity or the return on assets for any of the instruments. Our main policy implication is that R&D instruments for the business enterprise sector should be designed in favour of R&D-starters over R&D-incumbents, that is, shifting the focus from the intensive to the extensive margin. | en_US |
dc.language.iso | eng | en_US |
dc.rights | Navngivelse-DelPåSammeVilkår 4.0 Internasjonal | * |
dc.rights.uri | http://creativecommons.org/licenses/by-sa/4.0/deed.no | * |
dc.title | Public R&D support and firm performance: A multivariate dose-response analysis | en_US |
dc.type | Peer reviewed | en_US |
dc.type | Journal article | en_US |
dc.description.version | publishedVersion | en_US |
dc.rights.holder | © 2020 The Authors. Published by Elsevier B.V. | en_US |
dc.subject.nsi | VDP::Samfunnsvitenskap: 200::Økonomi: 210 | en_US |
dc.source.pagenumber | 16. | en_US |
dc.source.volume | 49 | en_US |
dc.source.journal | Research Policy | en_US |
dc.source.issue | 7 | en_US |
dc.identifier.doi | 10.1016/j.respol.2020.104067 | |
dc.identifier.cristin | 1830454 | |
dc.relation.project | Norges forskningsråd: 256240 | en_US |
dc.source.articlenumber | 104067 | en_US |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 2 | |